Tesseract Medical Research
Recent Finacing
Seed
Recent Raise
$20M
Tesseract Medicines develops covalent-induced-conjugate therapeutics that deliver cytotoxic payloads to cancer-relevant intracellular proteins, focusing on research and development of selective intracellular targeting to improve therapeutic index.
Highlights
Focus Areas
Alternative Medicine
Biotechnology
Fitness
Health Care
Wellness
Recent Investors
Financials
$20M
Total Raised
1
Funding round
3
Investors